Genomics News and Research

RSS

Genomics is the study of the complete genetic material, including genes and their functions, of an organism.

Researchers discover advances in predicting kidney failure in type 1 diabetes patients

In a paper published today in Science Translational Medicine, researchers from City of Hope, one of the largest cancer research and treatment organizations in the United States and a leading research center for diabetes and other life-threatening illnesses, report that they have discovered advances in predicting kidney failure in type 1 diabetes (T1D) patients.

22 May 2024

Ancient viral sequences in the human genome may contribute to psychiatric disorder susceptibility

New research led by King's College London has found that thousands of DNA sequences originating from ancient viral infections are expressed in the brain, with some contributing to susceptibility for psychiatric disorders such as schizophrenia, bipolar disorder, and depression.

22 May 2024

Study suggests miR-377 as potential therapeutic target for prostate cancer

A new research paper was published in Genes & Cancer on May 16, 2024, entitled, "Inhibitory effect of miR-377 on the proliferative and invasive behaviors of prostate cancer cells through the modulation of MYC mRNA via its interaction with BCL-2/Bax, PTEN, and CDK4."

22 May 2024

Single-cell analysis reveals insights into immune responses during xenotransplantation

Surgical teams at NYU Langone Health performed the world's first genetically modified pig kidney transplants into a human body in September and November 2021, and then transplanted two pig hearts in the summer of 2022.

22 May 2024

New drug-like molecules show promise in preventing influenza by blocking virus entry

Currently available flu medications only target the virus after it has already established an infection, but what if a drug could prevent infection in the first place?

21 May 2024

Generative AI enhances ER admission predictions with minimal training

Generative artificial intelligence (AI), such as GPT-4, can help predict whether an emergency room patient needs to be admitted to the hospital even with only minimal training on a limited number of records, according to investigators at the Icahn School of Medicine at Mount Sinai.

21 May 2024

ERS Genomics and IRBM sign CRISPR/Cas9 license agreement

ERS Genomics Limited (‘ERS’), the CRISPR licensing Company, and IRBM, a leader in the field of drug discovery, today announced a non-exclusive CRISPR/Cas9 license agreement. The agreement grants IRBM access to ERS’ CRISPR/Cas9 patent portfolio.

From ERS Genomics 21 May 2024

New CRISPR screen method reveals cellular drivers of neurological disorders

The brain is often referred to as a "black box"-;one that's difficult to peer inside and determine what's happening at any given moment.

20 May 2024

Researchers design new regenerative medicine therapy to accelerate diabetic wound repair

Researchers at the Icahn School of Medicine at Mount Sinai have designed a regenerative medicine therapy to speed up diabetic wound repair.

20 May 2024

World's first human mini-brain with a fully functional blood-brain barrier developed

In a pioneering achievement, a research team led by experts at Cincinnati Children's have developed the world's first human mini-brain that incorporates a fully functional blood-brain barrier (BBB).

20 May 2024

New study identifies key protein biomarkers for early detection of pancreatic cancer

Study used a Mendelian randomization approach to identify REG1A and REG1B as potential biomarkers for early detection of pancreatic cancer, showing their causal effects and significance in cancer screening.

19 May 2024

Climate change may negatively affect the health of people with brain conditions

Climate change, and its effects on weather patterns and adverse weather events, is likely to negatively affect the health of people with brain conditions, argue a UCL-led team of researchers.

16 May 2024

Azenta opens the doors to its new genomics laboratory in Oxford, UK

Azenta, Inc. today announced the grand opening of the new Genomics Laboratory in Oxford, UK, expanding its global reach of GENEWIZ Multiomics & Synthesis Solutions further in the UK market.

From Azenta Life Sciences 16 May 2024

Study reveals association between ribosomal DNA copy number and disease risk

Ribosomal DNA (rDNA) is present in hundreds of copies in the genome, but has not previously been part of genetic analyses.

15 May 2024

Scientists discover new insight into the genetic pathway of neuroblastoma

Scientists have discovered a new insight into the genetic pathway of childhood cancer, offering new hope for tailored treatments.

15 May 2024

Understanding public perception of polygenic embryo screening for IVF

Three out of four U.S. adults support the use of emerging technologies that estimate a future child's likelihood of developing health conditions influenced by multiple genes -; such as diabetes, heart disease, and depression -; before an embryo is implanted during in vitro fertilization (IVF), according to a new public opinion survey led by researchers at Harvard Medical School.

15 May 2024

Enhanc3D Genomics appoints Hazel Jones as Chief Executive Officer

Enhanc3D Genomics, a company developing disruptive technologies to unlock the 3D genome for use in novel target identification and unique patient stratification, today announced the appointment of Hazel Jones as Chief Executive Officer, after a successful six-month tenure as interim CEO and COO.

From Enhanc3D Genomics 15 May 2024

Genomics News and Research

Further Reading

Researchers discover advances in predicting kidney failure in type 1 diabetes patients

Ancient viral sequences in the human genome may contribute to psychiatric disorder susceptibility

Study suggests miR-377 as potential therapeutic target for prostate cancer

Single-cell analysis reveals insights into immune responses during xenotransplantation

New drug-like molecules show promise in preventing influenza by blocking virus entry

Generative AI enhances ER admission predictions with minimal training

ERS Genomics and IRBM sign CRISPR/Cas9 license agreement

New CRISPR screen method reveals cellular drivers of neurological disorders

Researchers design new regenerative medicine therapy to accelerate diabetic wound repair

World's first human mini-brain with a fully functional blood-brain barrier developed

New study identifies key protein biomarkers for early detection of pancreatic cancer

Climate change may negatively affect the health of people with brain conditions

Azenta opens the doors to its new genomics laboratory in Oxford, UK

Study reveals association between ribosomal DNA copy number and disease risk

Scientists discover new insight into the genetic pathway of neuroblastoma

Understanding public perception of polygenic embryo screening for IVF

Enhanc3D Genomics appoints Hazel Jones as Chief Executive Officer

Children with neurodevelopmental disorders face increased risk of congenital abnormalities

Unraveling the genetic connection between IBD and Parkinson's disease

Aficamten shows promise in enhancing exercise capacity in patients with hypertrophic cardiomyopathy

Sequencing & Genomics: Elevating Science and Healthcare eBook

Sensing a Healthier Future

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Latest Life Science News